Evidence map›Paper›PMID 26395152›Full record

ArticleGenome research2015

Enhanced virome sequencing using targeted sequence capture.

Todd N Wylie, Kristine M Wylie, Brandi N Herter, Gregory A Storch

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Genome research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03386227 (Prophylactic Antibiotics Prior to Embryo Transfer), which is not on this map. Cited by 157 papers.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03386227 naterminatednot on this mapstarted 2018, after this paper: background citation

Prophylactic Antibiotics Prior to Embryo Transfer: a Randomized Controlled Trial

TypeinterventionalSponsorWashington University School of MedicineRan2018 to 2019Enrolled96ConditionsAssisted Reproductive Technology, Antibiotic Prophylaxis, Embryo TransferArmsWithholding antibiotic prophylaxis
3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 271 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Application of targeted next-generation sequencing in children with community-acquired pneumonia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Gut virome dynamics: from commensal to critical player in health and disease.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Todd N WylieThe Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri 63108, USA.
Kristine M WylieThe Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri 63108, USA.
Brandi N HerterThe Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA;
Gregory A StorchThe Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA;
Washington University in St. Louis · US

Funding

DEFINING THE HUMAN VIROME IN IMMUNOCOMPROMISED CHILDRENR01AI097213 · NIAID · WASHINGTON UNIVERSITY · PI STORCH, GREGORY A. · 2012 to 2016
$3.2M
NIAID NIH HHS R01 AI097213NIAID NIH HHS R01AI097213
6 · The paper itself

Abstract

Metagenomic shotgun sequencing (MSS) is an important tool for characterizing viral populations. It is culture independent, requires no a priori knowledge of the viruses in the sample, and may provide useful genomic information. However, MSS can lack sensitivity and may yield insufficient data for detailed analysis. We have created a targeted sequence capture panel, ViroCap, designed to enrich nucleic acid from DNA and RNA viruses from 34 families that infect vertebrate hosts. A computational approach condensed ∼1 billion bp of viral reference sequence into <200 million bp of unique, representative sequence suitable for targeted sequence capture. We compared the effectiveness of detecting viruses in standard MSS versus MSS following targeted sequence capture. First, we analyzed two sets of samples, one derived from samples submitted to a diagnostic virology laboratory and one derived from samples collected in a study of fever in children. We detected 14 and 18 viruses in the two sets, comprising 19 genera from 10 families, with dramatic enhancement of genome representation following capture enrichment. The median fold-increases in percentage viral reads post-capture were 674 and 296. Median breadth of coverage increased from 2.1% to 83.2% post-capture in the first set and from 2.0% to 75.6% in the second set. Next, we analyzed samples containing a set of diverse anellovirus sequences and demonstrated that ViroCap could be used to detect viral sequences with up to 58% variation from the references used to select capture probes. ViroCap substantially enhances MSS for a comprehensive set of viruses and has utility for research and clinical applications.

Indexed as

High-Throughput Nucleotide SequencingMetagenomeMetagenomicsDNA, ViralGenome, ViralHumansRNA, ViralSensitivity and SpecificityVirusesDNA, ViralRNA, Viral

Identifiers

PMID26395152
PMCPMC4665012
OpenAlexW2175170082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.